Stroke AHA/ ASA,
#STROKE: The multicenter SPAN preclinical trial in more than 700 rodents shows that Rho kinase inhibitor Fasudil improves…
Multicenter SPAN Trial of Fasudil in Ischemic Stroke
Overview of attention for article published in Stroke, May 2025
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (89th percentile)
-
Good Attention Score compared to outputs of the same age and source (77th percentile)
Readers on
- mendeley
- 2 Mendeley